- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jennifer Gass Provides an Overview of FCS' Next-Generation Sequencing Laboratory
Jennifer Gass, PhD, FACMG, associate director, Genetics Laboratory, Florida Cancer Specialists & Research Institute, discusses the recent Genetics Laboratory, which focuses on next-generation sequencing (NGS) testing in oncology care.
The state-of-the-art Florida Cancer Specialists & Research Institute (FCS) laboratory provides next-generation sequencing (NGS) testing, which helps oncologists identify genetic mutations in hundreds of different genes, all at once.
Transcript
How are things going and who is the team at the team at the new NGS laboratory that opened about a year ago at FCS?
Our pathology lab is made up of 8 different pathologist, 2 laboratory geneticist, and multiple departments. My department is the molecular department, and we are the ones that run the next generation sequencing (NGS). And within that department, we have 10 technologists and 2 variants scientists, as well as a molecular manager to support our NGS testing.
Everything is going well! we launched our first NGS test in July of 2021 and now we have brought on another test, so we support both solid tumor and hematological malignancies. And we look forward to bringing on more technologies with NGS as well as more molecular technologies.
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
